To include your compound in the COVID-19 Resource Center, submit it here.

CRLX101: Interim Phase IIa data

Interim data from 20 evaluable patients with non-small cell lung cancer (NSCLC) in the Phase IIa portion of an ongoing,

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE